Send to

Choose Destination
Korean J Gastroenterol. 2017 Apr 25;69(4):226-231. doi: 10.4166/kjg.2017.69.4.226.

Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients.

Author information

Divisions of Gastroenterology, Inha University School of Medicine, Incheon, Korea.
Divisions of Infectious Diseases, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.



Fecal microbiota transplantation (FMT) is a highly effective therapy for refractory and recurrent Clostridium difficile infection (CDI). Despite its excellent efficacy and recent widespread use, FMT has not been widely used in South Korea thus far. We describe our experience with FMT to treat refractory/recurrent CDI.


We conducted a chart review of patients who underwent FMT for refractory/recurrent CDI at Inha University Hospital, between March 2014 and June 2016. The demographic information, treatment data, and adverse events were reviewed. FMT was administered via colonoscopy and/or duodenoscopy. All stool donors were rigorously screened to prevent infectious disease transmission.


FMT was performed in nine patients with refractory/recurrent CDI. All patients were dramatically cured. Bowel movement was normalized within one week after FMT. There were no procedure-related adverse events, except aspiration pneumonia in one patient. During the follow-up period (mean 11.4 months), recurrence of CDI was observed in one patient at one month after FMT due to antibiotics.


FMT is a safe, well-tolerated and highly effective treatment for refractory/recurrent CDI. Although there are many barriers to using FMT, we expect that FMT will be widely used to treat refractory/recurrent CDI in South Korea.


Clostridium difficile; Colonoscopy; Fecal microbiota transplantation; Gastrointestinal microbiome

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for The Korean Society of Gastroenterology
Loading ...
Support Center